Recently, it was revealed that the high-risk, poor-prognosis downregulation of GABA type A receptor-associated protein (GABARAP) causes a defect in both autophagy and surface exposure of calreticulin (CALR) in multiple myeloma (MM) cells responding to bortezomib. Hence, GABARAP-defective MM cells fail to undergo immunogenic cell death.
Johanna Mondésir, Margherita Ghisi, Laura Poillet-Perez, Robert A. Bossong, Oliver Kepp, Guido Guido Kroemer, Jean‐Emmanuel Sarry, Jérôme Tamburini, Andrew A. Lane
Discussion(0)
No comments yet. Be the first to comment.